- Aveanna Healthcare (AVAH) exhibits strong technical momentum, with a more-than-70% gain over the past year.
- Shares are trading at a new all-time high.
- Multiple analysts rate AVAH a “Strong Buy,” supported by robust growth, profitability, and valuation metrics.
- Technical indicators remain bullish: RSI above 70, 11 new highs in the past month, and a consensus price target near current levels.
Today’s Featured Stock
Valued at $3 billion, Aveanna Healthcare (AVAH) is a diversified home care platform focused on providing care to medically complex, high-cost patient populations.
What I’m Watching
I found today’s Chart of the Day by using Barchart’s powerful screening functions to sort for stocks with the highest technical buy signals and superior current momentum. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. AVAH checks those boxes. The Trend Seeker issued a new “Buy” signal on Aug.13. Since then, the stock has gained 18.11%.
Barchart’s Technical Indicators for Aveanna Healthcare
Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.
Aveanna Healthcare scored an all-time of $14 on Aug. 27.
- Aveanna has a Weighted Alpha of 77.21.
- AVAH has a 100% “Buy” opinion from Barchart.
- The stock has gained 70.22% over the past 52 weeks.
- Aveanna has its Trend Seeker “Buy” signal intact.
- The stock recently traded at $13.34 with a 50-day moving average of $10.16.
- AVAH had 10 new highs and gained 34.93% in the last month.
- 60-month beta of 1.90.
- Relative Strength Index (RSI) is at 71.50.
- There’s a technical support level around $13.56.
Don’t Forget the Fundamentals
- $3 billion market capitalization.
- 20.64x trailing price-earnings ratio.
- Revenue is projected to grow 10.51% this year and another 7.55% next year.
- Earnings are estimated to increase by 37.95% this year and an additional 6.88% next year.
Analyst and Investor Sentiment on Aveanna Healthcare
- The Wall Street analysts followed by Barchart give the stock 7 “Strong Buy,” 1 “Moderate Buy,” and 4 “Hold” opinions with price targets between $8 and $16.
- Value Line rates the stock “Average.”
- Morningstar thinks the stock is 7% overvalued with a fair value of $12.61.
- CFRA’s MarketScope rates the stock as “Strong Buy.”
- 3,960 investors are following the stock on Seeking Alpha, which rates it a “Strong Buy.”
- TipRanks’ analysts’ price targets are between $9.50 and $16.00 with a consensus price target of $13.92 for a 0.70% gain.
- Short interest is 2.02% of the float with 2.37 days to cover the float.
The Bottom Line on Aveanna Healthcare
This stock receives high marks on all evaluations: growth, profitability, momentum, analysts’ positive revisions, and valuation. What more could you want?
Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculate should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.
On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.